alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 60, Number 78 (Monday, April 24, 1995)]
[Notices]
[Page 20151]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-1004]



-----------------------------------------------------------------------



DEPARTMENT OF TRANSPORTATION

Executive Committee of the Aviation Rulemaking Advisory 
Committee; Meeting

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The FAA is issuing this notice to advise the public of a 
meeting of the Executive Committee of the Federal Aviation 
Administration Aviation Rulemaking Advisory Committee.

DATES: The meeting will be held on May 10, 1995, at 9 a.m. Arrange for 
oral presentations by April 28, 1995.

ADDRESSES: The meeting will be held at the Aerospace Industries 
Association of America, 1250 Eye Street, NW., Goddard A/B, Washington, 
DC, 9 a.m.

FOR FURTHER INFORMATION CONTACT:
Miss Jean Casciano, Federal Aviation Administration (ARM-25), 800 
Independence Avenue, SW., Washington, DC 20591, telephone (202) 267-
9683; fax (202) 267-5075.

SUPPLEMENTARY INFORMATION: Pursuant to section 10(a)(2) of the Federal 
Advisory Committee Act (Pub. L. 92-463; 5 U.S.C. App. II), notice is 
hereby given of a meeting of the Executive Committee to be held on May 
10, 1995, at the Aerospace Industries Association, 1250 Eye Street, 
NW., Goddard A/B, Washington, DC, 9 a.m. The agenda will include:
    <bullet> ARAC mailouts
    <bullet> A follow-up on open action items
    <bullet> A briefing on the digital information initiative
    <bullet> Notable comments on specific issues
    <bullet> EXCOM involvement in tasking and setting of priorities
    <bullet> Other business
    Attendance is open to the interested public but will be limited to 
the space available. The public must make arrangements by April 28, 
1995, to present oral statements at the meeting. The public may present 
written statements to the executive committee at any time by providing 
25 copies to the Executive Director, or by bringing the copies to him 
at the meeting. In addition, sign and oral interpretation can be made 
available at the meeting, as well as an assistive listening device, if 
requested 10 calendar days before the meeting. Arrangements may be made 
by contacting the person listed under the heading FOR FURTHER 
INFORMATION CONTACT.

    Issued in Washington, DC, on April 17, 1995.
Chris A. Christie,
Executive Director, Aviation Rulemaking Advisory Committee.
[FR Doc. 95-1004 Filed 4-21-95; 8:45 am]
BILLING CODE 4910-13-M
What Makes a Generic the Same 

as a Brand-Name Drug?

Pharmaceutical Equivalence

Lab test results and other documentation from the generic manufacturer 

are reviewed by FDA to demonstrate that:

The generic drug has the 

same active ingredient(s) 

as the brand-name drug.

The generic drug has the 

same dosage form as the 

brand-name drug.

The generic drug has the 

same strength and route 

of administration as the 

brand-name drug.

The generic drug has the 

same indications as the 

brand-name drug.

The inactive ingredients 

of the generic drug are safe 

and don’t change how the 

drug works.

The generic drug will 

work as intended for a 

reasonable amount of 

time before expiring.

Bioequivalence

Comparisons—often 

in human 

volunteers who take 

both the generic 

and brand-name 

drugs—ensure that:

The generic drug 

performs the same in 

the human body as the 

brand-name drug.

The generic drug is as 

safe and effective as 

the brand-name drug.

Appropriate 

Container and 

Labeling 

FDA inspection 

of the container 

and labeling 

demonstrates that:

The generic drug’s label 

is the same as the brandname drug’s label, with 

some exceptions—such as 

indications protected by 

patents or exclusivity.

The generic drug is 

sold and shipped in an 

appropriate container.

Appropriate 

Manufacturing

FDA inspection 

of facilities 

demonstrates that:

The generic drug meets 

the same requirements 

for identity, strength, 

purity, and quality as the 

brand-name drug does.

The manufacturer is capable 

of making the generic drug 

correctly and consistently.

Visit www.FDA.gov/GenericDrugs 

to learn more.
[Federal Register Volume 60, Number 83 (Monday, May 1, 1995)]
[Notices]
[Pages 21131-21132]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-10553]



-----------------------------------------------------------------------


DEPARTMENT OF DEFENSE

Patent Licenses; Non-Exclusive, Exclusive, or Partially 
Exclusive: Massachusetts Institute of Technology

AGENCY: Department of the Navy, Department of Defense.

ACTION: Intent to Grant Exclusive Patent License; Massachusetts 
Institute of Technology.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant to Massachusetts Institute of Technology, a revocable, 
nonassignable, exclusive license in the United States and certain 
foreign countries to practice the Government owned invention described 
in U.S. Patent Application Serial No. 08/080,418, ``Thermal Insulation 
of Wet Shielded Metal Arc Welds,'' filed 18 June 1993. [[Page 21132]] 
    Anyone wishing to object to the grant of this license has 60 days 
from the date of this notice to file written objections along with 
supporting evidence, if any. Written objections are to be filed with 
the Office of Naval Research, ONR 00CC, Ballston Tower One, Arlington, 
Virginia 22217-5660.

FOR FURTHER INFORMATION CONTACT: Mr. R.J. Erickson, Staff Patent 
Attorney, Office of Naval Research, ONR 00CC, Ballston Tower One, 800 
North Quincy Street, Arlington, Virginia 22217-5660, telephone (703) 
696-4001.

    Dated: April 21, 1995.
M.D. Schetzsle,
LT, JAGC, USNR, Alternate Federal Register Liaison Officer.
[FR Doc. 95-10553 Filed 4-28-95; 8:45 am]
BILLING CODE 3810-AE-M
[Federal Register Volume 60, Number 81 (Thursday, April 27, 1995)]
[Unknown Section]
[Page 20762]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-10364]



-----------------------------------------------------------------------

DEPARTMENT OF LABOR
[TA-W-30,792]


Pennzoil Products Company, Bradford, Pennsylvania; Investigations 
Regarding Certifications of Eligibility To Apply for Worker Adjustment 
Assistance; Correction

    This notice corrects the notice for petition TA-W-30,792 which was 
published in the Federal Register on March 17, 1995 (60 FR 14453) in FR 
Document 95-6659.
    This revises the date received and the date of petition on the 
tenth line of the third and fourth columns in the appendix table on 
page 14453. The date received should read ``February 6, 1995'' and the 
date of petition should read ``February 2, 1995'' in the third and 
fourth columns on the tenth line of the appendix table.

    Signed in Washington, D.C., this 18th day of April, 1995.
Victor J. Trunzo,
Program Manager, Policy and Reemployment Services, Office of Trade 
Adjustment Assistance.
[FR Doc. 95-10364 Filed 4-26-95; 8:45 am]
BILLING CODE 4510-30-M
Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Universal American Corp. (the "Registrant") for the quarter
ended September 30, 2009, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Richard A. Barasch, Chief Executive Officer of the Registrant, and Robert A.
Waegelein, Chief Financial Officer of the Registrant, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that to the best of his knowledge:



Date: October 30, 2009

/s/ RICHARD A. BARASCHRichard A. Barasch Chief Executive OfficerDate: October 30, 2009

/s/ ROBERT A. WAEGELEINRobert A. Waegelein Chief Financial Officer


A signed original of this written statement required by Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed filed with the Securities and
Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that Section. This certification is not to be
incorporated by reference into any filing of the Registrant under the Securities Act of 1933 or the Securities Exchange Act of 1934, irrespective of any general incorporation language contained in
such filing.

---



QuickLinks
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 96-7853
UNITED STATES OF AMERICA, Plaintiff - Appellee, versus KEVIN A. WAUGH, Defendant - Appellant.
Appeal from the United States District Court for the Eastern District of Virginia, at Alexandria. Albert V. Bryan, Jr., Senior District Judge. (CR-95-30-A, CA-96-1529-AM) Submitted: May 1, 1997 Decided: May 8, 1997 Before WIDENER and MURNAGHAN, Circuit Judges, and PHILLIPS, Senior Circuit Judge. Dismissed by unpublished per curiam opinion. Kevin A. Waugh, Appellant Pro Se. Glenn Cameron Alexander, OFFICE OF THE UNITED STATES ATTORNEY, Alexandria, Virginia, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Appellant seeks to appeal the district court's order denying his motion filed under 28 U.S.C.A. § 2255 (West 1994 & Supp. 1997). We have reviewed the record and the district court's opinion andfind no reversible error. Accordingly, we deny a certificate of appealability and dismiss the appeal on the reasoning of the district court. United States v. Waugh , Nos. CR-95-30-A; CA-96-1529-AM (E.D. Va. Oct. 24, 1996). We dispense with oral argument because thefacts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Universal American Corp. (the "Registrant") for the quarter
ended June 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Richard A. Barasch, Chief Executive Officer of the Registrant, and Robert A.
Waegelein, Chief Financial Officer of the Registrant, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that to the best of his knowledge:



Date: July 29, 2010

/s/ RICHARD A. BARASCHRichard A. Barasch Chief Executive OfficerDate: July 29, 2010

/s/ ROBERT A. WAEGELEINRobert A. Waegelein Chief Financial Officer


A signed original of this written statement required by Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed filed with the Securities and
Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that Section. This certification is not to be
incorporated by reference into any filing of the Registrant under the Securities Act of 1933 or the Securities Exchange Act of 1934, irrespective of any general incorporation language contained in
such filing.

---



QuickLinks
[Federal Register Volume 60, Number 85 (Wednesday, May 3, 1995)]
[Notices]
[Page 21827]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-10838]



-----------------------------------------------------------------------


DEPARTMENT OF THE INTERIOR

Saint-Gaudens National Historic Site, Cornish, New Hampshire; 
Draft General Management Plan/Environmental Impact Statement; Notice of 
Availability, Public Comment Period, and Public Meetings

    In accordance with the National Environmental Policy Act (P.L. 91-
190) the National Park Service (NPS), U.S. Department of the Interior, 
announces that the Saint-Gaudens National Historic Site Draft General 
Management Plan/Environmental Impact Statement will be available for 
public review and comment from May 12 to July 7, 1995.
    The draft document presents four alternatives for site management 
and addressing planning issues, including resource preservation and 
provision of visitor services. Following the review period and 
consideration of comments received, the National Park Service will 
prepare and make available the final GMP/EIS, which will guide the 
management of the site for twenty years.
    During the sixty-day review period, interested persons may review 
the document and make written comments to the Superintendent, Saint-
Gaudens National Historic Site, RR#3 Box 73 Cornish, NH 03745.
    The NPS will distribute a complete version of the draft for public 
and agency review. The plan will be available at local libraries as 
well. Inquiries and requests for copies of the complete draft should be 
directed to Saint-Gaudens NHS at (603) 675-2175.
    The NPS will hold public meetings during the sixty-day period on 
Tuesday, June 6, from 3:00 to 8:00 pm and on Wednesday, June 7 from 
3:00 to 5:00 pm at the Little Studio, Saint-Gaudens NHS, Cornish, NH.
Robert McIntosh,
Acting Regional Director.
[FR Doc. 95-10838 Filed 5-2-95; 8:45 am]
BILLING CODE 4310-70-P
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 792 Introduced in Senate (IS)]

<DOC>

117th CONGRESS
  2d Session
S. RES. 792

 Expressing support for the designation of November 2022 as ``National 
           Alpha-1 Antitrypsin Deficiency Awareness Month''.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           September 22, 2022

    Mr. Scott of Florida (for himself and Mr. Rubio) submitted the 
 following resolution; which was referred to the Committee on Health, 
                     Education, Labor, and Pensions

_______________________________________________________________________

                               RESOLUTION

 
 Expressing support for the designation of November 2022 as ``National 
           Alpha-1 Antitrypsin Deficiency Awareness Month''.

Whereas an estimated 1 in every 2,500 individuals in the United States have the 
        genetic disorder alpha-1 antitrypsin deficiency (referred to in this 
        preamble as ``Alpha-1'');
Whereas there are an estimated 19,000,000 carriers of Alpha-1 in the United 
        States who may pass Alpha-1 on to their children;
Whereas Alpha-1 can lead to lung destruction and is often misdiagnosed as asthma 
        or smoking-related chronic obstructive pulmonary disease (COPD);
Whereas Alpha-1 symptoms relating to the lungs include--

    (1) shortness of breath;

    (2) wheezing;

    (3) chronic bronchitis;

    (4) recurring chest colds;

    (5) less exercise tolerance;

    (6) year-round allergies; and

    (7) bronchiectasis;

Whereas Alpha-1 occurs when there is a lack of a protein in the blood called 
        alpha-1 antitrypsin, which is mainly produced by the liver;
Whereas Alpha-1 symptoms relating to the liver include--

    (1) unexplained liver disease or elevated liver enzymes;

    (2) eyes and skin turning yellow, known as jaundice;

    (3) swelling of the abdomen, known as ascites, or legs; and

    (4) vomiting blood;

Whereas Alpha-1 is the most commonly known genetic risk factor for emphysema;
Whereas Alpha-1 can affect individuals at any age;
Whereas Alpha-1 cannot be diagnosed by symptoms or by a medical examination 
        alone;
Whereas individuals who may have Alpha-1 must take a blood test to confirm a 
        diagnosis;
Whereas early diagnosis and avoiding risk factors, such as smoking, can help 
        prevent Alpha-1 from causing disease; and
Whereas November 2022 would be an appropriate month to designate as National 
        Alpha-1 Antitrypsin Deficiency Awareness Month to--

    (1) raise awareness about Alpha-1; and

    (2) encourage more individuals to get tested for Alpha-1 if they 
present symptoms: Now, therefore, be it

    Resolved, That the Senate supports the designation of November 2022 
as ``National Alpha-1 Antitrypsin Deficiency Awareness Month''.
                                 <all>
```
Exhibit 33.4.2

REPORT ON ASSESSMENT OF COMPLIANCE

First American Real Estate Solutions of Texas, L.P. (an indirect subsidiary of The
First American Corporation and the Asserting Party) is responsible for assessing compliance as of December 31, 2007, and for the period from January 1, 2007 through December 31, 2007 (the Reporting Period) with
the servicing criteria set forth in Title 17, Sections 229.1122(d)(1)(iv), (d)(2)(v), (d)(2)(vi), (d)(2)(vii), (d)(4)(xi), (d)(4)(xii) and (d)(4)(xiii) of the Code of Federal Regulations applicable to the Asserting Party (the Applicable
Servicing Criteria). The transactions covered by this report include all loans for residential and commercial mortgage loan outsourcing customers for which the Asserting Party served as the residential and commercial tax service provider
(the Platform).

The Asserting Party has assessed its compliance with the Applicable Servicing Criteria for the Reporting Period and has
concluded that the Asserting Party has complied, in all material respects, with the Applicable Servicing Criteria as of December 31, 2007, and for the Reporting Period with respect to the Platform taken as a whole.

PricewaterhouseCoopers LLP, an independent registered public accounting firm, has issued an attestation report on the assessment of compliance with the Applicable
Servicing Criteria as of December 31, 2007, and for the Reporting Period as set forth in this assertion.



|                                                    |  |                                         
|--------------------------------------------------- |  | ----------------------------------------
|FIRST AMERICAN REAL ESTATE SOLUTIONS OF TEXAS, L.P.
|By:                                                 |  | First American Real Estate Solutions LLC
|                                                    |  | General Partner                         
|                                                    | 
|                                                    |  | /s/ Lucy A. Przybyla                    
|                                                    |  | Lucy A. Przybyla                        
|                                                    |  | Senior Vice President                   
|                                                    |  | February 12, 2008
III 

117TH CONGRESS 

2D SESSION S. RES. 873 

To authorize the production of records by the Secretary of the Senate and 

the Senate Sergeant at Arms. 

IN THE SENATE OF THE UNITED STATES 

DECEMBER 14, 2022 

Mr. SCHUMER (for himself and Mr. MCCONNELL) submitted the following 

resolution; which was considered and agreed to 

RESOLUTION 

To authorize the production of records by the Secretary 

of the Senate and the Senate Sergeant at Arms. 

Whereas, the Secretary of the Senate and the Senate Sergeant at Arms have received subpoenas for Senate personnel records from the Department of Homeland Security for use as evidence in a pending administrative investigation and adjudication; 

Whereas, by the privileges of the Senate of the United States 

and Rule XI of the Standing Rules of the Senate, no evidence under the control or in the possession of the Senate can, by administrative or judicial process, be taken 

from such control or possession but by permission of the 

Senate; 

Whereas, when it appears that evidence under the control or 

in the possession of the Senate is needed for the proVerDate Sep 11 2014 01:56 Dec 15, 2022 Jkt 039200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\SR873.ATS SR873

dlhill on DSK120RN23PROD with BILLS
2 

SRES 873 ATS 

motion of justice, the Senate will take such action as will 

promote the ends of justice consistent with the privileges 

of the Senate: Now, therefore, be it 

1 Resolved, That the Secretary of the Senate and the 

2 Senate Sergeant at Arms are authorized to provide to the 

3 Department of Homeland Security records sought, respec4 tively, by the subpoenas issued to them. 

Æ 


dlhill on DSK120RN23PROD with BILLS
Elton BOLDUC, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D18-4839

District Court of Appeal of Florida, Second District.

June 19, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Denied.
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

Northern District of California

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

STANTON MCCLENDON,

Plaintiff,

v.

CAROLYN W. COLVIN,

Defendant.

Case No. 17-cv-00408-PJH 

ORDER RE APPLICATION TO 

PROCEED IN FORMA PAUPERIS

Re: Dkt. No. 2

Before the court is pro se plaintiff Stanton McClendon’s application to proceed in 

forma pauperis. Dkt. 2. The court finds that it is unable to make a decision on plaintiff’s 

application because of several discrepancies that require clarification. First, although 

plaintiff has indicated that he owns a home in response to question 5, he has not 

provided any estimate of the value of his home or any mortgage on the home. Moreover, 

because plaintiff has listed rent as among his expenses in response to question 8, it 

seems possible that the answer to question 5 was an error. Second, plaintiff has written 

“GA” in the “utilities” section of question 8. If plaintiff intended to indicate that he receives 

general assistance, then this income should be listed in response to question 2e, about 

receiving money from government sources.

The court cannot decide whether to waive the filing fee until these issues are 

clarified. Accordingly, plaintiff is hereby ORDERED to either refile his application to 

proceed in forma pauperis, or to respond in writing to clarify these two issues, no later 

than February 21, 2017.

IT IS SO ORDERED.

Dated: January 31, 2017

__________________________________

PHYLLIS J. HAMILTON

United States District Judge

Case 4:17-cv-00408-PJH Document 4 Filed 01/31/17 Page 1 of 1